Results 221 to 230 of about 32,827 (233)

Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer

Bioorganic Chemistry, 2021
Yujun Cui, Shengnan Liu, Qingzhi Gao
exaly  

Oxaliplatin and its derivatives – An overview

Coordination Chemistry Reviews, 2023
Paul D O'Dowd, Darragh F Sutcliffe, Darren M Griffith   +2 more
exaly  

NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling

Cancer Letters, 2018
Zejun Fang, Chaoju Gong, Waseem Hassan   +2 more
exaly  

The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells

Biomedicine and Pharmacotherapy, 2018
Abbas Pirpour Tazehkand, Maryam Akbarzadeh, Mohammad Reza Sadeghi   +2 more
exaly  

Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells

Cancer Chemotherapy and Pharmacology, 2005
Mary W Davey, Ross A Davey
exaly  

Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells

Biochemical and Biophysical Research Communications, 2017
Pengfei Zhang, Kuan Ning, Jian Jin
exaly  

Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

FEBS Letters, 2002
Laure Crabbe, Pierre Martineau
exaly  

Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis

Journal of Cellular Physiology, 2018
Hsi-Hsien Hsu, Rathinasamy Baskaran, Chuan-Chou Tu   +2 more
exaly  

Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells

Cancers, 2019
Riya Biswas, Ji He, Fabrice Merien
exaly  

Oxaliplatin in resistant colorectal cancer: efficacy predictors

Inpharma Weekly, 2001
openaire   +1 more source